Earlier this week the U.S. Food and Drug Administration (FDA) announced that it has ordered manufacturers of fluoroquinolones – including the antibiotics Cipro, Levaquin and other medications – to add a black box warning to their prescribing information.
According to the FDA, people taking a fluoroquinolone antibiotic have an increased risk of tendinitis and tendon rupture, a serious injury that could cause permanent disability.
To decrease your risk of a tendon rupture, you should stop taking fluoroquinolone if you have any tendon pain, swelling, or inflammation; avoid exercise and use of the affected area; and, contact your doctor immediately. Your doctor may recommend switching you to a different type of antibiotic.
The FDA warning includes the following fluoroquinolone antibiotics:
- Ciprofloxacin (marketed as Cipro and generic ciprofloxacin)
- Ciprofloxacin extended release (marketed as Cipro XR and Proquin XR)
- Gemifloxacin (marketed as Factive)
- Levofloxacin (marketed as Levaquin)
- Moxifloxacin (marketed as Avelox)
- Norfloxacin (marketed as Noroxin)
- Ofloxacin (marketed as Floxin and generic ofloxacin)